Almac, Northern Ireland’s largest pharmaceutical company, has ramped up its profits by nearly one third as demand for its drug development and manufacture soared.
It made £81 million in the full year to the end of September 2021, up from £64 million the previous year, on a revenue hike of nearly 9%.
The company, which is headquartered in Craigavon, said demand has grown for its services and it was involved in the development of over 300 life-saving drugs spanning more than 20 therapeutic areas including oncology, cardiology, immunology, gene therapy and neurology over the year.
